Vaccine News and Research

Latest Vaccine News and Research

Study explores SARS-CoV-2 seroprevalence among vaccinated hospital workers

Study explores SARS-CoV-2 seroprevalence among vaccinated hospital workers

Study explores neutralization of SARS-CoV-2 Omicron variant by subunit vaccine boosters

Study explores neutralization of SARS-CoV-2 Omicron variant by subunit vaccine boosters

Current evidence that vitamin D is effective against COVID-19 neurological sequelae

Current evidence that vitamin D is effective against COVID-19 neurological sequelae

Factors influencing cross-protective serological immunity against SARS-CoV-2 variants in Asians

Factors influencing cross-protective serological immunity against SARS-CoV-2 variants in Asians

Modeling study assesses the effectiveness facemasks before and after COVID-19 vaccination

Modeling study assesses the effectiveness facemasks before and after COVID-19 vaccination

Immunobridging study shows immunogenicity in adolescents receiving SARS-CoV-2 mRNA and inactivated vaccines

Immunobridging study shows immunogenicity in adolescents receiving SARS-CoV-2 mRNA and inactivated vaccines

New approach to send ‘friendly’ nano-particles into the body shows promising results

New approach to send ‘friendly’ nano-particles into the body shows promising results

Survey: About 16% of couples are discordant about COVID-19 vaccination

Survey: About 16% of couples are discordant about COVID-19 vaccination

Modifying red blood cells to create a promising new vehicle for vaccine delivery

Modifying red blood cells to create a promising new vehicle for vaccine delivery

Mice study shows how to improve long-term effectiveness of TB vaccine

Mice study shows how to improve long-term effectiveness of TB vaccine

Canadian scientist discusses about how society could better prepare for future pandemics

Canadian scientist discusses about how society could better prepare for future pandemics

Study shows the mutations leading to omicron variant did not help virus escape recognition by T cells

Study shows the mutations leading to omicron variant did not help virus escape recognition by T cells

In silico screening and testing of FDA approved drugs inhibiting SARS-CoV-2 spike protein cleavage

In silico screening and testing of FDA approved drugs inhibiting SARS-CoV-2 spike protein cleavage

Study indicates a 100 µg mRNA-1273 booster has acceptable safety and robust antibody response against SARS-CoV-2

Study indicates a 100 µg mRNA-1273 booster has acceptable safety and robust antibody response against SARS-CoV-2

Updated results from ongoing study on the effect of a BNT162b2 booster dose on anti-SARS-CoV-2 antibodies

Updated results from ongoing study on the effect of a BNT162b2 booster dose on anti-SARS-CoV-2 antibodies

Study suggests increased durability of immune responses towards SARS-CoV-2 spike protein after BNT62b2 booster

Study suggests increased durability of immune responses towards SARS-CoV-2 spike protein after BNT62b2 booster

Potent pan-β-CoV human monoclonal antibody has in vivo activity in multiple animal models

Potent pan-β-CoV human monoclonal antibody has in vivo activity in multiple animal models

Aminoglycoside antibiotic geneticin shows selective antiviral effect against SARS-CoV-2

Aminoglycoside antibiotic geneticin shows selective antiviral effect against SARS-CoV-2

Study shows competitive fitness of emerging SARS-CoV-2 variants linked to their distinctiveness relative to identified lineages

Study shows competitive fitness of emerging SARS-CoV-2 variants linked to their distinctiveness relative to identified lineages

Most cancer patients develop antibodies after receiving COVID-19 vaccine, study shows

Most cancer patients develop antibodies after receiving COVID-19 vaccine, study shows

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.